Notably, its overexpression was shown to alleviate Aβ-induced injury by targeting β-secretase (BACE1) [53], an aspartyl protease of the pepsin family whose concentrations and rates of activity are increased in AD brains and body fluids. Here, BACE1 is linked to Alzheimer disease.